Free Papers

Single site clinical outcomes of a new non-diffractive presbyopia correcting intraocular lens

Free Paper Details

First Author: R.Pérez SPAIN

Co Author(s):    A. Martínez   F. Poyales                 

Abstract Details

Purpose:

Purpose: To evaluate clinical outcomes of binocular implantation of a new non-diffractive presbyopia correcting intraocular lens, AcrySof IQ Vivity Model DFT015 at a single site.

Setting:

Miranza IOA, Madrid, Spain

Methods:

Methods: 14 randomized subjects were bilaterally implanted with the DFT015 and 11 with SN60WF (aspheric monofocal control), respectively at a single site in Spain. At 6 months post-op, MRSE and binocular uncorrected and best corrected distance (UDVA, CDVA, 4m), intermediate (UIVA, DCIVA, 66cm) and near visual acuity (UNVA, DCNVA, 40cm) were assessed. Binocular defocus curve and quality of vision (QoV, McAlinden) were also assessed at 6 months.

Results:

Results: Binocular UDVA and CDVA were 0 logMAR or better for both DFT015 and SN60WF. DFT015 provided > 1 line improvement in DCIVA, UIVA, DCNVA and UNVA compared to SN60WF. The binocular defocus curve for DFT015 demonstrated >0.5 increased depth of focus at 0.2 logMAR compared to SN60WF. For both groups, rate of very bothersome starbursts, halos, and glare were similar and low.

Conclusions:

Conclusion: In comparison with an aspheric monofocal IOL, these site level results indicate that the non-diffractive presbyopia correcting IOL improves near and intermediate vision without affecting distance vision while maintaining a monofocal visual disturbance profile.

Financial Disclosure:

... is employed by a for-profit company with an interest in the subject of the presentation